In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Hot Line: Late-Breaking Clinical Trials 2
Session

Event : ESC Congress 2017

Topic : Other

  • Session type : Hot Line
  • Date : 28 August 2017
  • Time : 11:00 - 12:48

18 presentations in this session

SPYRAL HTN OFF-MED Study

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2
  • Speaker : M Boehm (Homburg,DE)

Discussant review: SPYRAL HTN OFF-MED Study

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2
  • Speaker : B Williams (London,GB)

Panel discussion.

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2

Panel discussion.

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2

Panel discussion.

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2

The Viborg Vascular randomised screening trial

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2
  • Speaker : J Lindholt (Odense,DK)

Discussant review: The Viborg Vascular randomised screening trial

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2
  • Speaker : A Kates (St. Louis,US)

Panel discussion.

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2

Panel discussion.

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2

DETermination of the role of OXygen in suspected Acute Myocardial Infarction

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2
  • Speaker : R Hofmann (Stockholm,SE)

Discussant review: DETermination of the role of OXygen in suspected Acute Myocardial Infarction

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2
  • Speaker : D Newby (Edinburgh,GB)

Panel discussion.

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are